All In Biotech

Drug Trial Radar · NCT00304031

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Last checked: Nov 20, 2026Latest source record: Jun 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,173 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,173

Actual

Start

Jan 2006

Primary completion

Feb 2011

Study completion Dec 2016

Sponsor

Lead sponsor
Radiation Therapy Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); European Organisation for Research and Treatment of Cancer - EORTC; NRG Oncology
First posted
Mar 17, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with temozolomide may kill more tumor cells. It is not yet known which schedule of temozolomide when given together with radiation therapy is more effective in treating glioblastoma or gliosarcoma. PURPOSE: This randomized phase III trial is studying two different schedules of temozolomide to compare how well they work when given together with radiation therapy in treating patients with newly diagnosed glioblastoma or gliosarcoma.

Conditions

  • Brain and Central Nervous System Tumors

Interventions

  • Concurrent temozolomideDrug

    Daily oral temozolomide (75 mg/m2) up to 49 doses.

  • Concurrent radiation therapyRadiation

    60 Gy in 2 Gy fractions

  • 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycleDrug

    Oral temozolomide on days 1-5 of a 28-day cycle. Dose starts at 150mg/m2 for first cycle, increases to 200mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.

  • 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycleDrug

    Oral temozolomide on days 1-21 of a 28-day cycle. Dose starts at 75mg/m2 for first cycle, increases to 100mg/m2 for subsequent cycles if no unacceptable toxicity. Treatment repeats every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. Patients with responding disease may receive up to 6 more courses of temozolomide.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Overall Survival TimeTime frame: From randomization to last follow-up. Maximum follow-up at time of analysis was 4.4 years.

Locations

351 sites in 2 countries. Site status is shown where the registry gives one.

  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Arizona Oncology Services Foundation

    Phoenix, Arizona

  • Mayo Clinic Scottsdale

    Scottsdale, Arizona

  • Arizona Oncology - Tucson

    Tucson, Arizona

  • Auburn Radiation Oncology

    Auburn, California

  • Providence Saint Joseph Medical Center - Burbank

    Burbank, California

  • Radiation Oncology Centers - Cameron Park

    Cameron Park, California

  • Mercy Cancer Center at Mercy San Juan Medical Center

    Carmichael, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Kaiser Permanente Medical Center - Los Angeles

    Los Angeles, California

  • Radiation Oncology Center - Roseville

    Roseville, California

  • Radiological Associates of Sacramento Medical Group, Incorporated

    Sacramento, California

  • Mercy General Hospital

    Sacramento, California

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California

  • Solano Radiation Oncology Center

    Vacaville, California

  • Penrose Cancer Center at Penrose Hospital

    Colorado Springs, Colorado

  • Poudre Valley Radiation Oncology

    Fort Collins, Colorado

  • Yale Cancer Center

    New Haven, Connecticut

  • Tunnell Cancer Center at Beebe Medical Center

    Lewes, Delaware

  • CCOP - Christiana Care Health Services

    Newark, Delaware

  • Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus

    Boca Raton, Florida

  • University of Florida Shands Cancer Center

    Gainesville, Florida

  • Baptist Cancer Institute - Jacksonville

    Jacksonville, Florida

  • Integrated Community Oncology Network at Southside Cancer Center

    Jacksonville, Florida

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida

  • Baptist Medical Center South

    Jacksonville, Florida

  • Integrated Community Oncology Network

    Jacksonville Beach, Florida

  • Baptist-South Miami Regional Cancer Program

    Miami, Florida

  • Integrated Community Oncology Network - Orange Park

    Orange Park, Florida

  • Florida Cancer Center - Palatka

    Palatka, Florida

  • Flagler Cancer Center

    Saint Augustine, Florida

  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

    Tampa, Florida

  • Piedmont Hospital

    Atlanta, Georgia

  • John B. Amos Cancer Center

    Columbus, Georgia

  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

    Boise, Idaho

  • Northwest Community Hospital

    Arlington Heights, Illinois

  • Rush-Copley Cancer Care Center

    Aurora, Illinois

  • St. Joseph Medical Center

    Bloomington, Illinois

  • Graham Hospital

    Canton, Illinois

  • Memorial Hospital

    Carthage, Illinois

Showing 40 of 351 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.